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The gender of cancer
Ilana Löwy
1 While  some  cancers  are  strictly  sex-specific,  the  overall  incidence  of  cancer  is
nevertheless considered broadly similar in both sexes.1 This ‘gender-balanced’ view is a
relatively new development. Until mid-twentieth century, cancer was viewed as a disease
that affected mainly women. This view reflected the greater visibility of breast cancer
and cancers of the female reproductive organs. Before the advent of modern diagnostic
technologies,  doctors  often  failed  to  diagnose  malignant  tumors  of  internal  organs.
People suffered from digestive troubles, jaundice, “fits,” shortness of breath and “the
ailments of old age,” rather than from stomach, colon, liver, brain or lung cancer. On the
other hand, it was difficult to miss the dramatic changes in a cancer-affected breast, or
the massive blood loss and abundant vaginal secretions in advanced uterine cancer. In the
nineteenth  and  early  twentieth  century,  mortality  statistics  in  France  and  England
– while  far  from accurate –  recorded  nearly  three  times  more  cancer  deaths  among
women  than  among  men.  The  tide  turned  only  in  mid-twentieth  century,  with  the
increase of accurate diagnoses of malignancies of internal organs and the rapid rise in
deaths from lung cancer among men. 
2 This article focuses on the period when experts and organizations active in the area of
cancer prevention and treatment area spoke mainly about and to women.2 Drawing on
both primary and secondary research concerning Europe and North America, it explores
both  the  medical  discourse  and the  practices  related  to  the  treatment  of  women’s
cancers.3 
 
Mothers and sinners: female cancers in the nineteenth
century
3 In  the  nineteenth  century,  doctors  offered  a  variety  of  explanations  for  the  high
incidence  of  uterine  cancer  among women.  For  some,  immorality  and  sexual  excess
explained  the  appearance  of  malignancies.4 The  Canadian  doctor  Guillaume  Vallée
affirmed in 1826 that lower-class women who lived in cities suffered more often from
uterine cancer than those who lived in the countryside, a difference best explained by the
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greater moral laxity of city-dwellers.5 Other physicians noted, however, that prostitutes
were no more prone to uterine tumors than “honest” women. Still,  many physicians
enumerated among causes of such tumors masturbation, excessive sexual activity and
inordinate  sexual  desire,  syphilis  and  other  venereal  diseases,  abortion,  as  well  as
disorders of women’s “critical age” (menopause).
4 In 1842, a surgeon from Padua, Domenico Rigoni-Stern, demonstrated that nuns rarely
suffered from cancer of  the womb, while they had higher than average frequency of
breast tumors.6 The observation that the same group of women was unusually susceptible
to one kind of malignant tumor and unusually resistant to another kind, challenged the
widespread  belief  that  the  principal  cause  of  cancer  was  a  moral  propensity  or  a
hereditary predisposition to  develop malignancies  (“cancer  diathesis”).  Rigoni-Stern’s
observations also suggested that cancer of the womb might be linked with sexual activity.
The British physician J.W.C. Lever similarly stated in 1839 that unmarried women rarely
suffered from cancer of the uterus, suggesting7 that the development of this pathology
might be favored by childbirth. By the late nineteenth and early twentieth century, this
opinion had become widespread, and many gynecologists became persuaded that uterine
cancer  was  linked  not  to  sexual  excess,  but  to  the  damage  produced  by  multiple
pregnancies and traumatic childbirth. 
5 For much of the nineteenth century, doctors talked about a single type of cancer, that of
“the matrix”, but by the later years of the century, experts were making a distinction
between cancer of corpus uteri (later known as endometrial cancer), and – the then much
more frequent – cancer of the uterine cervix (cervical cancer). They believed that only
the  latter  disease  was  linked  with  low  socio-economic  status  and  with  post-partum
damage. Cervical cancer was more frequently found in poorer women, because they had
more children and had less means of access to proper medical care when they gave birth,
so were likely to suffer from more severe cervical tears.8 Poverty was also linked to faulty
hygiene, higher frequency of sexually transmitted diseases, miscarriage and abortion, all
of which facilitated the development of chronic inflammation of the cervix, seen as a
precursor  lesion  of  cervical  malignancy.  Sexuality  was  not  entirely  absent  from the
argument  on  links  between  poverty  and  uterine  tumors,  since  sexually  transmitted
diseases and abortions were seen as the consequence of the supposedly more lax sexual
mores  of  lower-class  women.  However,  in  the  first  half  of  the  twentieth  century,
numerous gynecologists believed that a higher occurrence of cervical cancer among poor
women was chiefly  the result  of  frequent  pregnancies,  inadequate medical  care,  and
harsh living conditions. This cancer had become the scourge of the poor mother.
 
Detecting and treating female malignancies
6 In the early nineteenth century, many physicians assumed that they could prevent at
least some of the suffering produced by uterine cancer through the treatment of cervical
lesions (“squirrhus”) before they became an irreversible “cancer”.9 In 1836, the French
gynecologist  Pierre  Téallier  compared  this  preventive  treatment  of  suspicious
gynecological lesions with the prevention of social unrest through the repression of its
first manifestations, both being more effective the earlier they were tackled.10 Téallier,
like other cancer experts, emphasized the importance of medical consultations as soon as
women observed suspicious symptoms, such as irregular bleeding. This was, however, a
difficult task. Women were reluctant to consult for minor gynecological troubles, and
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most women did not have the financial means to do so. As a result, they often saw a
doctor only when their tumor induced more serious symptoms. At that stage, specialists
wrote,  the illness  was  incurable  and the physician could only  observe its  inexorable
progress.11 
7 With  the  development  of  surgical  ablation  of  the  uterus  (hysterectomy)  in  the  late
nineteenth  century,  doctors  were  finally  able  to propose  a  therapy  for  uterine
malignancies. Hysterectomy was at first a very hazardous form of surgery with a high
mortality rate,  but gynecologists believed that it  should be attempted when possible,
given the alternative of a slow and painful death. In the early twentieth century, survival
rates of hysterectomy had improved, but this operation was ineffective if the cancer had
already spread to other parts of the body.12 Physicians continued therefore, this time with
more solid arguments, to urge women to consult a doctor as soon as they observed any
suspicious gynecological symptoms. Their goal was to increase the proportion of tumors
detected in an “operable” stage, that is, those limited to the uterus only.13
8 Anti-cancer  organizations  in  Europe  and  North  America  energetically  promoted  the
slogan, “if  detected early,  cancer can be cured”. If  one reads this phrase carefully,  it
merely  states  that  while  some  localized  malignant  tumors  are  curable,  all  the
disseminated ones  are  deadly.  The usual  interpretation of  this  slogan was,  however,
different. It strongly hinted that a patient who knows what early signs of cancer are, and
who promptly consults a competent doctor on observing such signs, has a good chance of
being cured. It also indirectly implied that patients who died from cancer might have
been at  least  partly  responsible  for  their  fate.14 Educational  campaigns  organized by
cancer experts and anti-cancer organizations often focused on female cancers (of breast
and uterus),  which were considered “treatable”. Such campaigns promoted an upbeat
message and downplayed the harsh realities and uncertain results of cancer treatment.15
 
Early detection of cancer of the uterus
9 Thanks to the “early detection” campaigns for cervical  cancer,  many women became
persuaded that they should see a physician rapidly if they observed symptoms such as
irregular bleeding.16 In the inter-war period, gynecologists discovered, however, that not
infrequently  a  woman  who  consulted  them  immediately  after  noticing  suspicious
gynecological symptoms had a disseminated, that is, incurable malignancy. The “early”
medical visit was sometimes too late.  The next step was to persuade “asymptomatic”
(that  is,  healthy)  women to undergo regular  gynecological  examinations,  in order  to
detect “silent” cervical lesions.17
10 In 1938, the Philadelphia gynecologist Catherine Macfarlane began a pilot program for an
early detection of cervical cancer. M Macfarlane’s original project was to provide free
gynecological  examinations  in  poor  areas  of  the  city.  Poor  women,  especially  black
women, had the highest frequency of uterine tumors. Since they could not afford visits to
a gynecologist, they were often diagnosed with advanced, incurable malignancies. The
local medical community, and the administrators of Women’s Medical College to which
she was affiliated, strongly opposed Macfarlane’s project, because physicians were afraid
that  a  free  distribution  of  medical  services  would  reduce  their  private  practice  and
introduce a dangerous percentage of “socialized medicine”. The Women’s Medical College
finally  approved  the  project,  but  on  condition  that  Macfarlane  would  examine  only
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women referred by their physicians – that is, those who could afford private health care.
Macfarlane’s program provided important insights into the natural history of cervical
tumors but was of no assistance to women who had the greatest need for early detection
of this malignancy.18
11 In  the  1950s,  physicians  developed  a  cheaper  and  simpler  alternative  to  regular
gynecological visits:  the cervical smear (Papanicolau or PAP test).  The test was labor-
intensive and difficult to standardize, but was nevertheless successfully transformed into
a “workable” tool  in screening for  the presence of  anomalies  of  the cervix.19 Cancer
specialists and organizations in North America and Europe strongly promoted cervical
smears.  The  UK  campaigns  had  a  direct  public  health  dimension.  Educational  films
produced in the UK in the early 1960s specifically targeted working class and migrant
women. These films sought to eliminate women’s fear of “the test” and of the treatment
involved  if  suspicious  cervical  lesions  were  found.  They  encouraged  women  to  take
responsibility for their own health, but above all stressed their duty, as mothers, to be
healthy for the sake of their children and partners. The films explained that treatment of
precancerous cervical lesions was simple and without danger for woman’s fertility or
sexual life. The latter affirmation was designed to persuade husbands, who sometimes
opposed testing for cervical tumors. Another argument directed at husbands was that a
spouse’s serious disease would disrupt their lifestyle: “no more nights out at the pub, no
more football on Saturdays, just staying home with all those noisy kids.”20 
12 In the US, cervical cancer was not presented as a public health issue or a pathology linked
with a lower socioeconomic status, but as an individual problem: every woman, these
films explained, was at risk from this disease. Accordingly, educational films in the US on
the  importance  of screening  for  cervical  malignancies  mainly  showed  middle-class
women in a middle-class setting. These films explained that regular PAP smears offered
women security, personal happiness and freedom from the threat of cancer.21 At the same
time, US educational materials also emphasized a woman’s duty to herself and her family
to undergo regular tests, and hinted that women who developed cervical cancer were, at
some level at least, responsible for their fate.
 
Early detection of breast cancer
13 Breast cancer was another malignancy presented as curable if detected early. Specialists
urged women to be vigilant about changes in their breasts, and if they discovered a lump
or  other  suspicious  change,  to  consult  a  doctor  immediately.  “Delaying”  a  medical
consultation, even by a few weeks, was presented as highly irresponsible behavior, which
deprived the “delaying” woman of any chance of a cure. After World War II, the “do not
delay” message was reinforced by the introduction of breast self-examination technique
(BSE); women were urged to do this monthly. The American Cancer Society published
posters and leaflets  in the 1950s and 60s explaining the dangers associated with the
neglect of BSE, illustrating its argument with testimonies by women who claimed that the
examination had saved their lives or,  occasionally, that they were dying from cancer
because  they  had  failed  to  perform  BSE  regularly.22 These  educational  materials
transmitted an implicit message that advanced breast cancer was a self-inflicted disease.
BSE was advocated in Europe too, although it was less widely adopted there than in the
US.23 
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14 Women who practiced BSE remained strongly attached to this method even when clinical
trials conducted in the 1990s had shown that it was not very efficient, perhaps because
this technique allowed them to believe that they could protect themselves from a dread
disease.24 Mammography  screening  was  developed  in  the  1960s  and  70s,  and  was
massively  diffused  from the  1980s  on,  in  spite  of  persistent  controversies  about  the
efficacy of this approach. Its rapid spread may be partly explained by women’s intense
attachment to this method, which gave them the impression, once more, that they could
themselves  control  the  risk  of  getting  breast  cancer.25 Debates  on  the  benefits  of
mammography remained, in the main, confined to specialists, and had limited visibility in
the public space.26 The majority of anti-cancer organizations enthusiastically supported
mammography screening, and women have tended to entertain very exaggerated ideas
about the capacity of  this  technique to reduce breast  cancer mortality.27 In a survey
carried out in 2009, 2% of French women gave an accurate estimate of the effectiveness of
mammography, 15% exaggerated its efficacy 10 times; 22%, 50 times; and 45%, 100 times
or more (16% answered that they did not know).28
15 Before  the  1980s,  women  were  invited  to  follow  their  doctor’s  advice.  Posters  and
propaganda films from that period frequently show a subdued and conservatively dressed
woman attentively  listening to  a  male  medical  practitioner.  By  contrast,  educational
materials  from  the  last  30  years  emphasize  women’s  self-empowerment,  and  show
energetic,  youthful and smiling women who proudly proclaim they take good care of
themselves through a regular screening of their breasts.29 In spite of great differences of
language and style, the message promoted in the 21st century is not very different from
the one propagated in the pre-women’s liberation period. Women are asked to submit
themselves to external control, and, at the same time, to appeal to clinical specialists. In
the apt expression of  the sociologist  Ann Robertson,  they are urged to “swallow the
panopticon.”30
 
Women doctors and female malignancies
16 In the nineteenth and early twentieth century, the only cure for cancer was surgery,
often of a radical kind. At the time, there were not many female doctors, and even fewer
female  surgeons.  Women  who  chose  a  surgical  career  often  specialized  in  “female
diseases,” including cancer. One of the early pioneers of surgical treatment of cancer of
the uterus in the US was Mary Dixon-Jones. Dixon-Jones had a far from orthodox career.
First  trained in general  medicine,  and practising homeopathy and hydrotherapy,  she
retrained as a surgeon in her late forties. She then founded the Women's Hospital of
Brooklyn, specializing in surgical treatment of gynecological diseases. Mary Dixon-Jones
was the first US surgeon to perform an ablation of the uterus in 1888, and believed that
this surgery should be proposed not only to women with confirmed cancer, but also to
those at risk of this disease.31 In the late nineteenth century, doctors concurred that many
of women’s health problems were linked to their reproductive functions. Nevertheless
attitudes towards surgical ablation of female reproductive organs, uterus and ovaries, as
a cure for “female diseases,” varied greatly. Some gynecologists strongly supported this
therapeutic approach, while others strongly criticized it.32 The controversial reputation
of gynecological surgery coupled with high mortality rates, and in the case of Dixon-Jones
a suspicion attached to women surgeons, produced an explosive mix.
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17 In 1889, Dixon-Jones was accused of second degree manslaughter after the death of her
patient Ida Hunt. The historian Regina Marantz Sanchez, who has studied Dixon-Jones’s
tumultuous career, presents evidence that Ida Hunt was a chronically ill young woman,
probably as a consequence of venereal disease acquired from her husband. Her surgery
may have been a  last  ditch effort  to  regain her  lost  health.  Some women,  Marantz-
Sanchez  argues,  sought  Dixon-Jones’s  clinic  precisely  because  she  advocated  radical
surgical measures.33 This was, however, a risky practice. Dixon-Jones was acquitted of
manslaughter, but a local newspaper, The Brooklyn Daily Eagle published a series of articles
accusing her of gratuitous cruelty to her patients, performing ill-advised operations, and
being  guilty  of  negligence  and  incompetence.  Dixon-Jones  unsuccessfully  sued  The
Brooklyn Daily Eagle for libel in 1892. Unable to clear her name in a highly publicized trial,
Dixon-Jones was obliged to abandon the directorship of her hospital and her surgical
practice.34 
18 Surgical  ablations  of  the  uterus  performed  by  the  British  surgeons  Louisa  Garrett
Anderson and Kate Platt were less controversial. Between 1901 and 1914 Anderson and
Platt  co-directed the surgical  ward of  the London’s  New Hospital  for  Women,  which
specialized  in  gynecological  operations.  They  strongly  advocated  radical  surgery  for
uterine tumors, a practice they developed in the late 1890s, and expanded in the first
decade of the twentieth century. In the 1880s, a quarter of all women who underwent an
ablation of the uterus died from its immediate effects or from post-operative infections.
By  1908,  Anderson  and  Platt  could  boast  that  this  surgery  had  become  much  less
dangerous; the mortality rate at their hospital was only 6.6%. They admitted that the
chance of a permanent cure of cancer through this operation was not very high, but, they
argued, even a low chance of cure was better than a certainty of a lingering, painful
death.35
19 Female surgeons such as Mary Dixon-Jones or Louisa Garrett Anderson embraced the
male surgeons’ ethics of daring behavior and willingness to take risks. This choice may
have been motivated by an aspiration to demonstrate that, as professionals, women were
no different from men. Other women physicians chose a different approach. They saw
themselves as spokespersons for their sex, and promoted treatments which they believed
were less harmful and more acceptable for women. Thus in Britain, women played an
important role in the development of radiation therapy for gynecological malignancies,
above all cancer of the cervix. In 1929, the British Medical Women’s Federation provided
funding for the Marie Curie Hospital,  dedicated to radiation therapy of gynecological
cancers and staffed exclusively by women doctors. Leaflets presenting the new hospital
explained that women nervous about consulting a male doctor would be able to talk to
another woman, who would able to understand the precise nature of their complaint. The
literature also reassured poorer people, who were often apprehensive about operations in
charity  hospitals,  fearing  that  doctors  would  use  their  bodies  to  test  experimental
surgical techniques. Radiation therapy did not generate such fears.36 
20 Women  physicians  were  also  attracted  to  radiation  therapy  for  cancer  because  this
domain opened new professional opportunities for them. In interwar France, a woman
doctor  had  no  chance  whatever  of  achieving  prominence  in  the  French  medical
hierarchy, of becoming an agrégée de médecine,  or head of department in a university
hospital, or of being appointed to a university chair. Institutions such as the Curie
Foundation in Paris,  and the Villejuif  Cancer Institute,  at  the margins  of  the official
academic medicine system, were more able to promote women’s careers. Several women
The gender of cancer
Clio, 37 | 2013
6
physicians became pioneers of “curietherapy” – the French term for radiation therapy.
One of  them,  Simone Laborde,  head of  the  radiation therapy service  at  the  Villejuif
Cancer Institute, developed in the 1930s an innovative approach to radiotherapy. Cancer,
Laborde argued, is not an alien enemy but a diseased part of the body. The destruction of
healthy tissues through excessive radiation not only produced more severe side effects,
but reduced the body’s ability to deal with malignant cells.  Laborde strongly opposed
therapeutic strategies grounded in the belief that in the “war against cancer” more is
always  better.37 Her  objections  to  “heroic  therapies”  may  have  been  grounded  in
awareness of the concrete experience of her patients.  Some women feared secondary
effects of radiation more than the cancer itself. One Canadian woman who refused to
undergo radiotherapy for cancer of the uterus in the 1930s explained that,
three of my friends had similar treatment and they told me they were dying a death
of a fiery internal furnace. Knowing of their untimely deaths and awful agony, I was
determined to die comfortably, if needs be by the inroads of cancerous growths.38
 
Preventive surgery and women: from the nineteenth to
the twenty-first century
21 Laborde’s physiological understanding of cancer was a minority view. The majority of
experts viewed cancer as a particularly dangerous enemy, and many saw the preventive
elimination of “precancerous” tissues and organs as an especially efficient way to fight
this enemy.39 This approach was, however, limited almost exclusively to women’s cancers.
The accessibility of these cancers explains in part why they became targets of preventive
surgery. Another and perhaps even more important reason was the existence of a long
tradition  of  surgical  excision  of  women’s  reproductive  organs,  whether  diseased  or
healthy.40
22 Feminists have often criticized doctors’ lack of sensitivity to women’s needs, and their
wish  to  control  female  reproductive  functions.  Already  in  the  nineteenth  century,
activists protested against the surgical ablation of ovaries (“the de-sexing of women”)
and unnecessary hysterectomies. They presented these operations as typical expressions
of the brutal treatment of women by the medical profession.41 Recent scholarship has
nuanced this interpretation, however, suggesting that radical surgery was directed more
against tumors than against women. Writing about the medical culture of breast cancer
treatment  in  the  nineteenth  century,  Erin  O’Connor  has  argued that  the  nineteenth
century discourse about breast cancer reflected the harsh reality of suffering induced by
advanced  breast  malignancies.  Doctors  who  watched  women  die  painful  deaths
desperately  tried  to  do  something  to  prevent  such deaths.42 The  feminist  sociologist
Barbara  Rothman  has  similarly  concluded  that  surgeons  who  opposed  conservative
surgery for breast cancer were not driven by misogyny but by a concern to do the best for
their patients while limiting their own risk of making medical mistakes.43 
23 Attitudes  towards  radical  surgical  treatment  of  already  existing  and  invasive
malignancies were indeed not very different for both sexes. Men also had a full share of
“heroic” and mutilating surgeries, notably for the treatment of head and neck tumors.
The latter tumors, linked to smoking and to alcohol consumption, were more frequently
found in men. On the other hand, surgery for the elimination of a cancer risk – that is
preventive ablation of breasts, ovaries and the uterus – was almost exclusively practiced
on  women.  One  exception  was  a  rare  hereditary  form  of  colon  cancer,  familial
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adenomatous polyposis,  treated by preventive removal  of  the colon.  However,  in the
latter case, prophylactic surgery was proposed only to people (of both sexes) who were
almost certain to develop colon cancer. Breast cancer was a very different case. Doctors
recommended  preventive  surgery  to  women  even  for  lesions  whose  probability  of
becoming cancerous were unknown: e.g., women with precancerous transformations of
breast tissue (ductal carcinoma in situ, or DCIS), and carriers of mutations of the BCRA
gene which increased their chances of developing breast and ovarian tumors.44
24 American epidemiologists  claimed that  women presenting with a  small tumor in the
breast, or genetic predisposition to this cancer were increasingly opting for preventive
removal of both breasts.45 Such a radical decision was linked to
the never-ending awareness campaigns that have left many women in perpetual
fear of the disease […] Because breast cancer is  a disease that is  so emotionally
charged and gets so much attention, I think at times women feel almost obligated to
be as proactive as possible - that’s the culture of breast cancer.46 
25 Preventive  treatment  of  cancers  of  the  female  reproductive  organs  – which  may  be
contrasted  with  the  more  conservative  treatment  of  risk  of  cancer  in  the  male
reproductive  organs –  may  have  been  encouraged  by  the  greater  visibility  of  these
pathologies.47 Such visibility probably reflects the long tradition of debates and public
campaigns focused on women’s cancers. Breast cancer is omnipresent in the media and in
the public  space.  It  has also became a quasi-ritualized literary topic,  with a flood of
“pathographies” (personal narratives of diseases), essays, novels, photographs and other
art works. This is not the case for prostate cancer. In spite of its high incidence, prostate
cancer is rarely discussed in the media and popular books, and is seldom noticeable in the
public space.48 In spite of its “official” image as a disease that strikes indiscriminately at
both sexes, in the twenty-first century too cancer remains a gendered pathology. 
BIBLIOGRAPHY
ARONOWITZ, Robert. 2001. Do not delay: breast cancer and time 1900-1970. The Milbank Quarterly 79
(3): 355-386.
ARONOWITZ, Robert. 2007. Unnatural History: breast cancer and American society. New York.
Cambridge University Press.
BANKS, James, MARMOT, Michel, OLDFIELD, Zoe, and James P. SMITH. 2006. Disease and disadvantage
in the United States and England. Journal of the American Medical Association 295(17): 2037-2045.
BLOODGOOD, Joseph Colt [circa 1916] What Every One Should Know About Cancer. AMA leaflet: 4-6.
BURSTEIN, Harold J., POLYAK, Kornelia, WONG, Julia, LESTER, Susan, and Carolyn M. KAELIN. 2004.
Ductal carcinoma in situ of the breast. New England Journal of Medicine 350(14): 1430-1441.
CANTOR, David. 2007. Uncertain enthusiasm: the American Cancer Society, public education and
the problem of the movie, 1921-1960. Bulletin of the History of Medicine 81(1): 39-69.
The gender of cancer
Clio, 37 | 2013
8
CASPER, Monica J., and Adele E. CLARKE. 1998. Making Pap smear into the ‘right tool’ for the job: 
cervical cancer screening in the USA, circa 1940-1995. Social Studies of Science 28(2): 255-290.
CLOW, Barbara. 2001. Who’s afraid of Susan Sontag? Or the myths and metaphors of cancer
reconsidered. Social History of Medicine 14(2): 293-312.
DIXON-JONES, Mary A. 1893. Colpo-hysterectomy for malignant disease. American Journal of
Obstetrics and Diseases of Women and Children 27(4-5): 107-118. 
EISINGER, François, GELLER, Gail, BURKE, William, and Neil. A. HOLTZMAN. 1999. Cultural basis for
differences between and French clinical recommendations for women at increased risk of breast
and ovarian cancer. The Lancet 353: 919-920.
GARDNER, Kirsten E. 2006. Early Detection: women, cancer, and awareness campaigns in the twentieth-
century United States. Chapel Hill. University of North Carolina Press. 
GARRETT ANDERSON, Louisa, and Kate PLATT. 1908. Malignant disease of the uterus: a digest of 265
cases treated in the New Hospital for Women. Obstetrics and Gynaecology of the British Empire 14(6):
381-392.
GIGERENZER, Gert, MATA, Jutta, and Ronald FRANK. 2009. Public knowledge of benefits of screening
for breast and prostate cancer in Europe. Journal of the National Cancer Institute 101(17): 1216-1220.
GREEN, Beverly B., and Stephen H. TAPLIN. 2003. Breast cancer screening controversies. Journal of
the American Board of Family Medicine 16(3): 233-241.
GROOPMAN, Jerome. 2000. The Prostate Paradox: prostate cancer. The New Yorker, 29 May: 52-64.
HACKSHAW, Allan K., and Elizabeth A. PAUL. 2003. Breast self-examination and death from breast
cancer: a meta-analysis. British Journal of Cancer 88(7): 1047-1053.
HUGENIN, René. 1946. L’apport de la France dans l’étude du cancer. In Ce que la France a apporté à la
médicine, ed. A. Théophile ALAJOUANINE et al., 141-172. Paris. Flammarion.
JANSEN, Patricia. 2011. Menopause and the construction of cancer risk. Canadian Bulletin of Medical
History 28(1): 43-70.
JORGERSEN, Karsten Juhl, and Peter GOTZSCHE. 2004. Presentation of websites on possible benefits
and harms from screening for breast cancer: cross sectional study. British Medical Journal 328:
148-154. 
KING, Samantha. 2006. Pink Ribbons Inc.: breast cancer and the politics of philanthropy. Minneapolis.
Minnesota University Press.
KLOTZ, Laurence. 2006. Active surveillance with selective delayed intervention for favorable risk
prostate cancer. Urological Oncology 24(1): 46-50.
LAUDON, Irving. 1988. Maternal mortality (1880-1950): some regional and international
comparisons. Social History of Medicine 1(2): 183-228.
LEGOUX, Léon. 1826. Considérations sur les maladies cancéreuses en général. Paris. Didot le Jeune. 
LERNER, Barron. 2001. The Breast Cancer Wars: hope, fear and the pursuit of a cure in twentieth-century
America. New York. Oxford University Press.
LEVER, John Charles Weaver. 1839. Statistical notices on one hundred and twenty cases of
carcinoma uteri. Medico-Chirurgical Transactions 22: 267-273.
LÖWY, Ilana. 2009. Preventive Strikes: women, pre-cancer and preventive surgery. Baltimore. Johns
Hopkins University Press.
The gender of cancer
Clio, 37 | 2013
9
LÖWY, Ilana. 2011. Woman’s Disease. Oxford. Oxford University Press.
MACFARLANE, Catherine, STURGIS, Margaret C., and Faith FETTERMAN. 1953. Periodic examination of
the female pelvic organs and breasts: a report of fifteen years research on the control of cancer. 
CA, Cancer Journal for Clinicians 3: 205-207. 
MEIGS, Charles D. 1859 [4th edn]. Woman: Her Diseases and Remedies. Philadelphia. Blanchard & Lea.
MILLIGAN, Anstruth. 1907. The crusade against cancer of the uterus. Journal of Obstetrics and
Gynaecology 11: 45-63.
MORANTZ-SANCHEZ, Regina. 1999. Conduct Unbecoming a Woman: medicine on trial in nineteenth-century
Brooklyn. New York. Oxford University Press.
MORANTZ-SANCHEZ, Regina. 2000. Negotiating power at the bedside: historical perspectives on
nineteenth-century patients and their gynaecologists. Feminist Studies 26(2): 287-309.
MOSCUCCI, Ornella. 1990. The Science of Woman: gynaecology and gender in England, 1800-1929.
Cambridge. Cambridge University Press.
MOSCUCCI, Ornella. 2005. Gender and cancer in Britain, 1860-1910: the emergence of cancer as a
public health concern. American Journal of Public Health 95(8): 1312-1321.
MOSCUCCI, Ornella. 2007. The ineffable masonry of sex: feminist surgeons and the establishment of
radiotherapy in early twentieth-century Britain. Bulletin of the History of Medicine 81: 139-163.
MUKHERJEE, Siddhartha. 2010. The Emperor of all Maladies: a biography of cancer. New York. Simon
and Schuster.
NEKHLYUDOV, Larissa, ROSS-DEGNANT, Denis, and Susanne W. FLETCHER. 2003. Beliefs and
expectations of women under 50 years old regarding screening mammography. Journal of General
Internal Medicine 18: 182-189.
NOLTE, Karen. 2008. ‘Carcinoma uteri’ and ‘debouchery-morality, cancer and gender in the
nineteenth century’. Social History of Medicine 21(1): 31-46.
O’CONNOR, Erin. 2000. Raw Material: producing pathology in Victorian culture. Durham, N.C. Duke
University Press.
PATTERSON, James. 1987. The Dread Disease: cancer and modern American culture. Cambridge, Mass.
Harvard University Press.
PARKER-POPE, Tara. 2013. Facing cancer, a stark choice. New York Times, 21.1.2013.
PICHEVIN, Antoine. 1912. La lutte contre le cancer d’utérus. Journal de Médicine de Paris: 151-153. 
REAGAN, Leslie. 1997. Engendering the dread disease: women, men and cancer. American Journal of
Public Health 87(11): 1179-1187.
ROBERTSON, Anne. 2001. Biotechnology: political rationality and discourses on health risk. Health
5/3: 293-309. 
ROSSIGNOL, Jean Auguste. 1806. Essai sur le cancer de l’utérus. Montpellier. Imprimerie Coucourdan.
ROTHMAN, Barbara Katz. 1998. The Book of Life: a personal and ethical guide to race, normality and the
implications of the Human Genome Project. Boston. Beacon Press.
SCOTTO, Joseph, and John BAILARD. 1969. Rigoni Stern and medical statistics: a nineteenth-century
approach to cancer research. Journal of the History of Medicine and Allied Sciences 24(1): 65-75.
The gender of cancer
Clio, 37 | 2013
10
TÉALLIER, Pierre Jérôme Sébastien. 1836. Du Cancer de la matrice, de ses causes, son diagnostic et son
traitement. Paris. Ballière.
TOON, Elisabeth. 2007. Cancer as the general population knows it: knowledge, fear and lay
education in twentieth-century Britain. Bulletin of the History of Medicine 81(1): 116-138.
VALLÉE, Guillaume. 1826. Dissertation sur le cancer de l’utérus. Paris. Imprimerie Didot Jeune.
WALKOWITZ, Judith. 1980. Prostitution in Victorian Society: Women, Class and the State. Cambridge.
Cambridge University Press.
WARDLE Jane, STEPTOE Andrew, SMITH Heather et al. 1995. Breast self-examination: attitudes and
practices among young women in Europe. European Journal of Cancer Prevention 4(1): 61-68.
WELCH, Gilbert. 2004. Should I be Tested for Cancer? Maybe not and here’s why, Berkeley. University of
California Press.
NOTES
1. Banks et al. 2006. Their data deal only with overall frequency of cancers, and not with the
distribution of specific cancers. 
2. Reagan 1997; Moscucci 2005; Jansen 2011.
3. Aronowitz 2001; Gardner 2006; Löwy 2009 and 2011.
4. Nolte 2008. Breast cancer was less strongly linked with specific lifestyle elements than cancer
of the womb.
5. Vallée 1826: 10.
6. Scotto & Bailard 1969.
7. Lever 1839.
8. Laudon 1988: 183-228.
9. Meigs 1859: 333.
10. Téallier 1836: 108. 
11. Rossignol 1806: 23; Legoux 1826: 35. 
12. Moscucci 2005.
13. Bloodgood [ca 1916]. 
14. Patterson 1987; Lerner 2001.
15. Gardner 2006: 53-92.
16. Milligan 1907; Pichevin 1912.
17. Annual rapport of the Curie Foundation for 1932. Minutes of meeting of the foundation’s
administration council of 4 May 1934. Curie Institute Archive, Paris.
18. Catherine  Macfarlane papers.  Medical  College of  Philadelphia  archive,  account 47,  Box 2,
Folder 23, typed ms “The inside history of periodic pelvic examination research”; Macfarlane,
Sturgis & Fetterman 1953. 
19. Casper & Clark 1998.
20. Wellcome Library, Archives and Manuscripts Dept, series SA/MWF, Documents of the Medical
Women Federation, File F.13/10. Documents from the Meeting of the “Film Working Party of the
Women’s National Cancer Control Campaign,” 13/12/67.
21. Cantor 2007.
22. Aronowitz 2001; Gardner 2006.
23. Wardle et al. 1995; Eisinger et al. 1999.
24. Green & Taplin 2003; Hackshaw & Paul 2003.
The gender of cancer
Clio, 37 | 2013
11
25. The diffusion of  mammography coincided with a reduction in breast  cancer mortality in
many industrialized countries.  However, the spread of this technique also coincided with the
development  of  important  therapeutic  innovations.  It  is  therefore  difficult  to  evaluate  the
mammography’s contribution (if any) to this decline in breast cancer mortality. Welch 2004. 
26. Jorgersen & Gotzsche 2004. 
27. Nekhlyudov, Ross-Degnant & Fletcher 2003. 
28. Gigerenzer, Mata & Frank 2009. Women also had exaggerated perceptions of the contribution
of mammography to the reduction of the number of mastectomies.
29. Gardener 2006; Toon 2008.
30. Robertson 2001: 293-309.
31. Dixon-Jones 1893.
32. Moscucci 1990.
33. Morantz-Sanchez 2000: 301. 
34. Morantz-Sanchez 1999.
35. Garrett Anderson & Platt 1908. 
36. Moscucci  2007:  158.  Radiotherapy  for  cancer  was  introduced  in  the 1910s;  by  contrast
chemotherapy for breast and uterine tumors became routine treatment of these malignancies
only in the 1980s.
37. Quoted by Hugenin 1946: 166.
38. Clow 2001: 301.
39. Siddhartha Mukherjee’s  bestselling book,  The Emperor  of  all  Maladies:  a  biography of  cancer
illustrates the continued popularity of the concept of a “war against cancer”. Mukherjee 2010.
40. Moscucci 1990.
41. Walkowitz 1980; Moscucci 1990.
42. O’Connor 2000: 78-99. O’Connor is aware of the misogyny of nineteenth-century surgeons, but
argues that it did not play an important role in their choice of cancer treatments.
43. Rothman 1998: 154-158.
44. Burstein et al. 2004; Aronowitz 2007: 257-282.
45. Lerner 2001.
46. Parker-Pope 2013.
47. E.g., Groopman 2000; Klotz 2006.
48. On the political underpinning of breast cancer charities activities see e.g. King 2006.
ABSTRACTS
Today cancer is seen as a disease that affects both sexes roughly equally. This is,  however, a
relatively  recent  development.  Until  the  mid-twentieth  century,  cancer  was  viewed  as  a
pathology mainly affecting women, because female malignancies produced typical  symptoms,
and were easier to detect. In the twentieth century, women’s cancers – of breast and uterus –
became the principal targets of public campaigns to promote the early detection of malignant
tumours.  From the 1950s on,  the development of  more efficient  diagnostic  methods and the
increase in the prevalence of lung cancer, a disease found more often in men, put an end to the
image of cancer as a female pathology. On the other hand, cancers of female reproductive organs
continue to be more visible in public discourse and the media than those of male reproductive
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organs, and preventive – and mutilating – forms of surgery are more often proposed for women
at risk from these pathologies. 
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